| Name | NBI-921352 |
|---|
| Description | NBI-921352 (XEN901) is a potent inhibitor of sodium channels, specially targeting Nat/1.6 channels. NBI-921352 (XEN901) treats the nervous system pathologies of epilepsy effectively without adverse side effects (extracted from patent WO2017201468A1)[1]. |
|---|---|
| Related Catalog | |
| Target |
Nat/1.6 channels[1] |
| References |
| Molecular Formula | C22H25FN4O2S2 |
|---|---|
| Molecular Weight | 460.59 |